Beauvais_1997_Infect.Immun_65_3042

Reference

Title : Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans - Beauvais_1997_Infect.Immun_65_3042
Author(s) : Beauvais A , Monod M , Wyniger J , Debeaupuis JP , Grouzmann E , Brakch N , Svab J , Hovanessian AG , Latge JP
Ref : Infect Immun , 65 :3042 , 1997
Abstract :

A dipeptidyl-peptidase IV was purified from the culture medium of the human-pathogenic fungus Aspergillus fumigatus. The enzyme has an apparent molecular mass of 95 kDa and contained approximately 10 kDa of N-linked carbohydrate. This glycoprotein is antigenic and has all characteristics of the class IV dipeptidyl-peptidases: removal of Xaa-Pro and to a lesser extent Xaa-Ala dipeptides from the N termini of peptides, including bioactive peptides such as neuropeptide Y, [des-Arg1] bradykinin, and glucagon-like peptide 1, activity at neutral pH, and presence in the amino acid sequence of the Gly-X-Ser-X-Gly consensus motif of the serine-hydrolases and the putative catalytic triad (Ser613, Asp690, His725) of the dipeptidyl-peptidases. Moreover, the last 200 amino acids displayed 60 to 65% similarity with the other dipeptidyl-peptidases IV from rat, mouse, human, and yeast. However, unlike the other dipeptidyl-peptidases, the dipeptidyl-peptidase IV of A. fumigatus is a secreted enzyme with a cleavable signal peptide. Expression of a recombinant dipeptidyl-peptidase IV of A. fumigatus has been attained in the yeast Pichia pastoris.

PubMedSearch : Beauvais_1997_Infect.Immun_65_3042
PubMedID: 9234752
Gene_locus related to this paper: aspfu-DPP4

Related information

Substrate Gly-Pro-pNA    Lys-Pro-MNA    Arg-Pro-pNA    Ala-Pro-pNA    Gly-Phe-pNA
Gene_locus aspfu-DPP4
Family DPP4N_Peptidase_S9

Citations formats

Beauvais A, Monod M, Wyniger J, Debeaupuis JP, Grouzmann E, Brakch N, Svab J, Hovanessian AG, Latge JP (1997)
Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans
Infect Immun 65 :3042

Beauvais A, Monod M, Wyniger J, Debeaupuis JP, Grouzmann E, Brakch N, Svab J, Hovanessian AG, Latge JP (1997)
Infect Immun 65 :3042